talazoparib,atezolizumab
pfizer,roche
['atezo', 'talazo', 'sclc', 'lcsm,(-blcsm)']
s1929 #asco23 presented by a phase ii study of maintenance atezolizumab vs atezolizumab plus talazoparib in pts with slfn11 positive extensive-stage sclc pfs with talazoparib (2.8 mo vs 4.2 mo; hr 0.70) #lcsm 
Assistant Prof | Thoracic Oncology & Phase-I @karmanoscancer | EIC @BTFCancerNews | Previously @MayoCancerCare @gundersenhealth @JeffHealthAb | Tweets my own